接受放疗或放化疗的头颈癌患者胃造瘘管置入的预测因素:一项系统综述
该系统综述纳入16项回顾性研究(n=11015),评估头颈癌患者接受放疗或同步放化疗后胃造瘘管置入的风险因素。胃造瘘管置入总体发生率为44%,其中76%为反应性置入。治疗前吞咽困难、治疗前BMI<18.5和下咽肿瘤是预防性置入的显著预测因素;化疗方案类型、鼻咽肿瘤和细胞因子变化是反应性置入的显著预测因素。
要点
- 胃造瘘管置入总体发生率为44%,76%为反应性置入。
- 治疗前吞咽困难、BMI<18.5和下咽肿瘤预测预防性置入。
- 化疗方案类型、鼻咽肿瘤和细胞因子变化预测反应性置入。
核心结论
- 识别出多个增加胃造瘘管置入风险的因素,可能指导现有决策算法。
研究设计与样本
- 系统综述,纳入16项回顾性研究,共11015例头颈癌患者。
主要发现
- 胃造瘘管置入总体发生率为44%,其中76%为反应性置入。
- 治疗前吞咽困难、治疗前BMI<18.5和下咽肿瘤是预防性胃造瘘管置入的显著预测因素。
- 化疗方案类型、鼻咽肿瘤和细胞因子变化是反应性胃造瘘管置入的显著预测因素。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Malnutrition is a major problem in head and neck cancer (HNC) with up to half of patients requiring gastrostomy tube (G-tube) placement. Predicting this need remains complex given mixed evidence surrounding its usage. METHODS: A comprehensive search was performed to identify studies examining risk factors associated with G-tube placement following radiotherapy (RT) or concurrent chemoradiotherapy (CCRT) in HNC patients. RESULTS: Sixteen retrospective studies were included (n = 11 015). The overall prevalence of G-tube placement was 44% with 76% of patients receiving reactive G-tube placement. Pretreatment dysphagia, pretreatment BMI < 18.5, and tumors in the hypopharynx were significant predictive factors for prophylactic G-tube placement. Type of chemotherapy regimen, tumors in the nasopharynx, and cytokine changes were significant predictive factors for reactive G-tube placement. CONCLUSION: Several factors were identified that contribute to increased risk of G-tube placement and may guide current decision-making algorithms.
引用
- Xiao JB, Cherukupalli A, Tran KL, et al. Predictors of Gastrostomy Tube Placement in Head and Neck Cancer Patients Undergoing Radiation or Chemoradiotherapy: A Systematic Review. Head Neck. 2024. PMID: 39587806. doi:10.1002/hed.28010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。